West Pharmaceutical Services Aktie
| 304,04USD | -3,16USD | -1,03% |
WKN: 864330 / ISIN: US9553061055
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,40 |
| The Vanguard Group, Inc. | 12,43 |
| Vanguard Group, Inc. (Subfiler) | 11,96 |
| State Street Corp. | 4,44 |
| Artisan Partners Holdings LP | 4,23 |
| Walter Scott & Partners Ltd. | 3,81 |
| AllianceBernstein LP | 3,59 |
| BlackRock Fund Advisors | 3,44 |
| APG Asset Management NV | 3,19 |
| Vanguard Total Stock Market ETF | 3,18 |
| Franklin Advisers, Inc. | 3,11 |
| Brown Advisory LLC | 3,03 |
| Stichting Pensioenfonds ABP (Global Equity Portfolio) | 2,95 |
| Vanguard 500 Index Fund | 2,62 |
| Geode Capital Management LLC | 2,40 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 8 200 | 9 200 | 10 065 | 10 700 | 10 600 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,22 | 0,23 | 0,28 | 0,27 | 0,28 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 059 | 1 374 | 1 742 | 1 920 | 1 936 |
| Summe Anlagevermögen | 1 283 | 1 420 | 1 572 | 1 697 | 1 893 |
| Summe Aktiva | 2 341 | 2 794 | 3 314 | 3 617 | 3 830 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 329 | 326 | 325 | 318 | 309 |
| Summe Fremdkapital | 768 | 939 | 978 | 932 | 949 |
| Summe Eigenkapital | 1 573 | 1 855 | 2 335 | 2 685 | 2 881 |
| Summe Passiva | 2 341 | 2 794 | 3 314 | 3 617 | 3 830 |
Adresse
| 530 Herman O. West Drive, 19341-0645 Exton | |
| Telefon | +1 (610) 594-2900 |
| Fax | +1 (800) 345-9800 |
| Internet | http://www.westpharma.com |
Management
|
Annette F. Favorite
Chief Human Resources Officer & Senior VP |
|
Bernard J. Birkett
Chief Financial Officer |
|
Chad R. Winters
Chief Accounting Officer, VP & Controller |
|
Chris Ryan
Senior Vice President-Containment & Glass Systems |
|
Cindy Reiss-Clark
Chief Commercial Officer & Senior Vice President |
|
Deborah L. V. Keller
Independent Director |
|
Donald A. McMillan
Vice President-Enterprise Business Systems |
|
Douglas A. Michels
Independent Director |
|
Eric Mark Green
Chairman, President & Chief Executive Officer |
|
Kathy dePadua
Chief Quality Officer & Vice President |
|
Kimberly Banks MacKay
Secretary, General Counsel & Senior Vice President |
|
Mark A. Buthman
Independent Director |
|
Molly E. Joseph
Independent Director |
|
Myla P. Lai-Goldman
Independent Director |
|
Paolo Pucci
Lead Independent Director |
|
Quintin John Lai
Vice President-Strategy & Investor Relations |
|
Robert F. Friel
Independent Director |
|
Robert Segura
Vice President-Corporate Development |
|
Rudy Poussot
Senior VP-Strategy & Corporate Development |
|
Silji Abraham
Chief Technology Officer & Senior Vice President |
|
Stephen H. Lockhart
Independent Director |
|
Thomas W. Hofmann
Independent Director |
|
William F. Feehery
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
